# US 2024/0002816 A1 · Engineered transaminase polypeptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002816 A1
- Document ID: US20240002816A1
- Status: Published application
- Kind: A1
- Application number: 18/459,797
- Filed: 2023-09-01
- Published: 2024-01-04
- Earliest claimed: 2020-04-10
- Assignees: Codexis, Inc.
- Applicants: Codexis, Inc.
- Inventors: Scott J. Novick; Nikki Dellas
- Web page: https://patentgrep.com/patent/US20240002816A1

## CPC

- C12N 9/1096: {transferring nitrogenous groups (2.6)}
- C12P 17/182: {Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The present disclosure provides engineered transaminase polypeptides useful for the synthesis of chiral amine compounds under industrially relevant conditions. The disclosure also provides polynucleotides encoding the engineered transaminase polypeptides, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases for the production of chiral amine compounds.

## Claims

### Claim 1

An engineered polynucleotide encoding an engineered transaminase having an amino acid sequence of at least 85% identity to SEQ ID NO: 4, 8, 366, or 650, or a functional fragment thereof, and at least one substitution or a set of substitutions in said amino acid sequence relative to SEQ ID NO: 4, wherein the positions of said substitutions are numbered with reference to SEQ ID NO: 4, 8, 366, or 650.

### Claim 2 (depends on 1)

The polynucleotide of claim 1, wherein the engineered transaminase has at least 85% sequence identity to SEQ ID NO: 4 and comprises at least one substitution or set of substitutions at one or more positions selected from: 21/163/286/291/314/316/323/383/388/408/414/416, 18, 20, 21, 21/23/56/146, 21/23/56/146/432, 21/23/146/417, 21/23/395/417/432, 21/53/56, 21/53/417, 21/56/395, 21/417/432, 23, 23/53, 23/53/56, 23/53/56/146/395, 23/53/395, 23/53/417, 23/53/432, 23/56, 23/56/395, 23/56/395/417, 23/395/417, 23/417, 23/417/432, 53, 53/56, 53/146/417, 53/395, 56, 56/74/241/286/314/316/323, 56/86/163/314/316/383/414/416/422, 56/86/286/314/414/416, 56/86/314/316/323/394/414/422, 56/146/417, 56/146/432, 56/147, 56/163, 56/163/286/316/323/383/394, 56/286/314/316/323/422, 56/286/383, 56/323, 56/323/383, 56/323/383/394, 56/383, 56/395, 74/81/286/316/323/383, 74/85/86/163/286/316/323/394, 74/85/314/316/414/416, 74/86/163/316, 74/86/316/323/383/394, 74/88/286/316/323/383, 74/88/323/383, 74/163/286/316/383/394/416, 74/163/314/316, 74/163/314/316/323/394, 74/163/314/323/383/414/416, 74/286, 74/286/316/323, 74/286/394/416, 74/314/323/383/394/414, 74/316/323/394, 85/86/88/163/323/383/394, 85/86/163/314/323/394/414, 85/286, 85/286/323, 86, 86/88/163/323/383/414/422, 86/383/394, 88, 88/163/286/383, 88/286/316/323, 88/286/316/323/383/414/416, 88/316/323, 146, 146/147/395/417, 146/395, 146/395/417, 146/417, 147/395/417/432, 147/417, 149, 157, 163, 163/222/286/316/323/383/394, 163/286, 163/286/314/316/323/414/416, 163/286/314/323/394, 163/286/316/323/394/416, 163/286/414, 163/314/316/394, 163/314/323/394, 163/314/383, 163/314/414, 163/316/323, 163/323, 163/383, 164, 199/417, 259, 260, 284, 286, 286/314/323/383, 286/314/394, 286/316/323/383/414/416, 286/316/383/394, 286/316/394/414/416, 286/323, 286/323/383/414, 286/323/416, 286/383, 286/416, 314/316, 314/316/323, 314/316/323/383/422, 314/316/323/394, 314/316/394, 314/323/383/394, 314/383, 314/383/414/422, 315, 316, 316/323/383/394, 316/323/394/414/416, 316/414/422, 323, 323/383, 323/383/394/414/416, 323/394, 383, 395, 395/417, 395/417/432, 400, 401, 403, 404, 405, 406, 408, 415, 417, 417/432, 420, and 422.

### Claim 3 (depends on 1)

The polynucleotide of claim 1, wherein the engineered transaminase has at least 90% sequence identity to SEQ ID NO: 4 and comprises at least one substitution or set of substitutions at one or more positions selected from: 74/81/286/316/323/383, 163/286/314/316/323/414/416, 163/286/314/323/394, 286/314/323/383, 286/316/323/383/414/416, 315, and 408, wherein the amino acid positions are numbered with reference to SEQ ID NO:4.

### Claim 4 (depends on 1)

The polynucleotide of claim 1, wherein said polypeptide sequence has at least 85% sequence identity to SEQ ID NO: 8 and comprises at least one substitution or set of substitutions at one or more positions selected from: 5, 18/23/149/260/383/395/401/416, 18/23/149/383, 18/163/164, 21, 21/163/315/316, 21/163/323/408, 21/408, 23/56/86/149/163/164/383/401/416, 23/86, 23/149/260, 23/149/284/383/395, 23/163/164/383, 23/163/164/401/416, 24, 42, 42/110, 42/187/272, 42/187/324/363/366, 42/187/353, 42/272/291, 42/272/291/363, 42/272/324/363/366, 42/272/363/410, 42/272/410, 42/291/313/363/410, 42/291/363, 42/291/363/366, 42/353, 42/363, 46, 66, 77, 86/149/163/164/383/395/401, 86/149/395, 86/163/164/260/383, 86/383, 107, 110, 110/187, 110/187/253/410, 134, 138, 149/164/260/383/395/401, 149/260/383, 149/416, 163/259/323/408, 163/259/408, 163/315/316, 164/260/401, 164/316/383/401, 167, 186, 187, 187/253/363/366, 187/272/324/363/410, 187/272/363, 187/272/363/366/410, 187/291, 189, 191, 195, 199, 203, 210, 211, 248, 259/307, 260/395/401, 272, 272/353, 272/363/366, 272/410, 277, 291, 305, 309, 315, 342, 343, 351, 354, 358, 361, 362, 363, 363/366, 365, 367, 383, 383/401, 383/416/422, 385, 388, 389, 392, 395, 396, 401, 404, 405, 408, 410, 416, 417, 439, 443, 447, 450, and 451, and wherein the amino acid positions are numbered with reference to SEQ ID NO:8.

### Claim 5 (depends on 1)

The polynucleotide of claim 1, wherein the polypeptide sequence has at least 90% sequence identity to SEQ ID NO: 8, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence at one or more positions selected from: 18/23/149/383, 21/163/323/408, 272, 291, and 383, and wherein the amino acid positions are numbered with reference to SEQ ID NO:8.

### Claim 6 (depends on 1)

The polynucleotide of claim 1, wherein the engineered transaminase has at least 85% sequence identity to SEQ ID NO: 366 and at least one substitution or set of substitutions at one or more positions selected from: 24, 24/42/66/291, 24/42/291/362, 24/66/163/191/362/383/388, 24/66/191/199/260/291/351, 24/66/191/199/291, 24/66/191/260/408, 24/66/260/291/383/388/408, 24/66/291/342/383, 24/66/291/365, 24/66/342/365/388/408, 24/77/291, 24/107/163/191/291/351/383/388, 24/107/291/351/365/388, 24/163/351/383, 24/191/291/365, 24/199/260/351/362/383, 24/199/260/362/383/388, 24/260/362/383/388, 24/291, 24/291/342/351/383, 24/291/362/388, 24/291/408, 24/383/388, 24/388, 25, 28, 33, 42/191/408, 42/199/291/383, 42/291/351/362/365/383/388, 42/291/351/362/383/408, 42/291/383/388, 66/82/291/383, 66/163/191/365/383, 66/199/351/383, 66/291, 66/291/362/365/383, 66/291/383/388, 66/383, 77/291, 77/383/388, 86, 107/191/199/365/383/388, 107/191/291/383, 148, 153, 163/291/362/365/383/388, 163/291/383/388, 163/383, 191/199/365/383/388, 191/260/388, 191/291, 191/291/342/362/365, 191/351/383/388, 199/260/383, 199/291, 260, 260/291/365/383/408, 260/365/383, 291, 291/351/383/388, 291/351/383/388/408, 291/362/365, 291/365/388, 291/383, 314, 315, 316, 319, 342/362, 351/383/388, 362, 362/388, 383, 383/388, 396, 397, 405, 406, 413, 419, and 423, and wherein the amino acid positions are numbered with reference to SEQ ID NO:366.

### Claim 7 (depends on 1)

The polynucleotide of claim 1, wherein the engineered transaminase has at least 90% sequence identity to SEQ ID NO: 366 and comprises at least one substitution or set of substitutions at one or more positions selected from: 24/66/191/199/291, 24/66/291/365, 163/291/362/365/383/388, 163/291/383/388, 191/291/342/362/365, 291, and 291/383, and wherein the amino acid positions are numbered with reference to SEQ ID NO:366.

### Claim 8 (depends on 1)

The polynucleotide of claim 1, wherein the engineered transaminase has at least 85% sequence identity to SEQ ID NO: 650 and comprises at least one substitution or set of substitutions at one or more positions selected from: 10, 13, 13/24/108/163, 13/24/108/163/311, 13/24/133/199/311, 13/24/163, 13/24/199/311, 13/108, 13/108/199, 13/108/311, 13/199, 13/311, 14, 14/24/108, 14/24/108/133, 14/24/108/199, 14/24/199, 14/108, 14/108/133/311, 14/108/311, 14/311, 24, 24/163, 24/163/199, 35, 72, 73, 78, 95, 101, 108, 108/199, 114, 154, 163, 169, 175/316, 199, 199/311, 226, 293, 311, 316, 382, 383, and 386, and wherein the amino acid positions are numbered with reference to SEQ ID NO:650.

### Claim 9 (depends on 1)

The polynucleotide of claim 1, wherein the engineered transaminase has at least 90% sequence identity to SEQ ID NO: 650 and comprises at least one substitution or set of substitutions at one or more positions selected from: 14/108/133/311, 24/163/199, 72, 78, 316, and 383, and wherein the amino acid positions are numbered with reference to SEQ ID NO:650.

### Claim 10 (depends on 1)

The polynucleotide of claim 1, wherein said polynucleotide sequence is operably linked to a control sequence.

### Claim 11 (depends on 1)

The polynucleotide of claim 1, wherein said polynucleotide sequence is codon optimized.

### Claim 12 (depends on 1)

The polynucleotide of claim 1, wherein the engineered transaminase exhibits an increased enzymatic activity.

### Claim 13 (depends on 1)

An expression vector comprising at least one polynucleotide sequence of claim 1.

### Claim 14 (depends on 13)

A host cell comprising at least one expression vector of claim 13.

### Claim 15 (depends on 1)

A host cell comprising at least one polynucleotide sequence of claim 1.

### Claim 16 (depends on 15)

A method of producing an engineered transaminase in a host cell, comprising culturing the host cell of claim 15, under suitable conditions, such that at least one engineered transaminase is produced.

### Claim 17 (depends on 16)

The method of claim 16, further comprising recovering at least one engineered transaminase from the culture and/or host cell.

### Claim 18 (depends on 17)

The method of claim 17, further comprising the step of purifying said at least one engineered transaminase.

### Claim 19

An engineered polypeptide having transaminase activity, wherein the polypeptide comprises an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 4, or a functional fragment thereof, wherein said amino acid sequence comprises at least one amino acid substitution or set of amino acid substitutions at a position or set of positions numbered with reference to SEQ ID NO: 4 selected from: 21/163/286/291/314/316/323/383/388/408/414/416, 18, 20, 21, 21/23/56/146, 21/23/56/146/432, 21/23/146/417, 21/23/395/417/432, 21/53/56, 21/53/417, 21/56/395, 21/417/432, 23, 23/53, 23/53/56, 23/53/56/146/395, 23/53/395, 23/53/417, 23/53/432, 23/56, 23/56/395, 23/56/395/417, 23/395/417, 23/417, 23/417/432, 53, 53/56, 53/146/417, 53/395, 56, 56/74/241/286/314/316/323, 56/86/163/314/316/383/414/416/422, 56/86/286/314/414/416, 56/86/314/316/323/394/414/422, 56/146/417, 56/146/432, 56/147, 56/163, 56/163/286/316/323/383/394, 56/286/314/316/323/422, 56/286/383, 56/323, 56/323/383, 56/323/383/394, 56/383, 56/395, 74/81/286/316/323/383, 74/85/86/163/286/316/323/394, 74/85/314/316/414/416, 74/86/163/316, 74/86/316/323/383/394, 74/88/286/316/323/383, 74/88/323/383, 74/163/286/316/383/394/416, 74/163/314/316, 74/163/314/316/323/394, 74/163/314/323/383/414/416, 74/286, 74/286/316/323, 74/286/394/416, 74/314/323/383/394/414, 74/316/323/394, 85/86/88/163/323/383/394, 85/86/163/314/323/394/414, 85/286, 85/286/323, 86, 86/88/163/323/383/414/422, 86/383/394, 88, 88/163/286/383, 88/286/316/323, 88/286/316/323/383/414/416, 88/316/323, 146, 146/147/395/417, 146/395, 146/395/417, 146/417, 147/395/417/432, 147/417, 149, 157, 163, 163/222/286/316/323/383/394, 163/286, 163/286/314/316/323/414/416, 163/286/314/323/394, 163/286/316/323/394/416, 163/286/414, 163/314/316/394, 163/314/323/394, 163/314/383, 163/314/414, 163/316/323, 163/323, 163/383, 164, 199/417, 259, 260, 284, 286, 286/314/323/383, 286/314/394, 286/316/323/383/414/416, 286/316/383/394, 286/316/394/414/416, 286/323, 286/323/383/414, 286/323/416, 286/383, 286/416, 314/316, 314/316/323, 314/316/323/383/422, 314/316/323/394, 314/316/394, 314/323/383/394, 314/383, 314/383/414/422, 315, 316, 316/323/383/394, 316/323/394/414/416, 316/414/422, 323, 323/383, 323/383/394/414/416, 323/394, 383, 395, 395/417, 395/417/432, 400, 401, 403, 404, 405, 406, 408, 415, 417, 417/432, 420, and 422.
